Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adacel booster immunogenicity and safety study in healthy children, adolescents, and adults in China
2015-003941-24Phase 3
- Sponsor
- Sanofi
- Start
- Jan 2016
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of acellular pertussis vaccine, diphtheria toxoid adsorbed + tetanus toxoid adsorbed and tetanus and diphtheria toxoids adsorbed in diphtheria, Tetanus and pertussis (4 arms), sponsored by Sanofi. Primary endpoint: Diphtheria and tetanus antibody concentrations.
02
Drugs
acellular pertussis vaccinediphtheria toxoid adsorbed + tetanus toxoid adsorbedtetanus and diphtheria toxoids adsorbed
03
Conditions
diphtheriaTetanuspertussis
Beyond the preview
Go deeper on 2015-003941-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003941-24.